Australia markets closed

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.65+0.66 (+6.01%)
At close: 04:00PM EDT
11.50 -0.15 (-1.29%)
Pre-market: 09:21AM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2021
30/09/2020
30/09/2019
30/09/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
35,907
32,984
25,232
22,260
13,344
Selling general and administrative
12,047
9,018
5,857
6,847
5,989
Total operating expenses
47,954
41,947
30,938
28,808
19,185
Operating income or loss
-47,954
-41,947
-30,938
-28,808
-19,185
Total other income/expenses net
2,589
4,280
4,501
2,539
1,580
Income before tax
-45,115
-37,641
-26,258
-26,213
-17,381
Income tax expense
290.497
267.565
22.664
82.181
72.746
Income from continuing operations
-45,406
-37,909
-26,280
-26,295
-17,453
Net income
-45,406
-37,909
-26,280
-26,295
-17,453
Net income available to common shareholders
-45,406
-37,909
-26,280
-26,295
-17,453
Basic EPS
-
-0.54
-0.45
-0.54
-0.39
Diluted EPS
-
-0.54
-0.45
-0.54
-0.39
Basic average shares
-
69,803
58,195
48,906
44,656
Diluted average shares
-
69,803
58,195
48,906
44,656
EBITDA
-
-41,947
-30,938
-28,808
-19,185